{'text': 'Novartis Acquires Remaining Rights to Ofatumumab by GSK for...', 'publisher': {'href': 'https://multiplesclerosisnewstoday.com', 'title': 'Multiple Sclerosis News Today'}, 'created_at': 'Mon, 24 Aug 2015 07:00:00 GMT', 'description': 'Novartis Acquires Remaining Rights to Ofatumumab by GSK for...  Multiple Sclerosis News Today', 'url': 'https://news.google.com/rss/articles/CBMikAJBVV95cUxNVDN4NzEwWllENEpJVVg3TW9pU3NXM05NajdWRkNFVkNibXk1eTJYQnpzZFdrZTlWTFdZVmF4SC1YMUFCdUtmRzNON1ExMEI1N1BrZVRacjA1bG5MX1VpbExZVXdBZnpKZ28yc0VDNU1EZHVBeUdHcjVzOTBTemp4Yk5oaTh3QlBOLXNFWVc5Y1VXaEphN3FvZFZ2RFkyMGV4NzNzdTZZUnZlMDVsTFh6ZjdrX29PcXg5eWlsSHpNdnVoZXI3VFRab2ZQS3NSLWVBN3Bsc2dwYzg4LVB0UUMxOV9taHM3X1ZNc3Q5V0hXcjFZTVJtN3JfU0tTV2ZfVFdSd2Z5c3lTbHM0SFJxVXlrMw?oc=5&hl=en-US&gl=US&ceid=US:en'}
{'text': 'New Tool Calculates Cost-Benefit Analysis for Cancer Treatments - Voice of America', 'publisher': {'href': 'https://www.voanews.com', 'title': 'Voice of America - VOA News'}, 'created_at': 'Mon, 24 Aug 2015 07:00:00 GMT', 'description': 'New Tool Calculates Cost-Benefit Analysis for Cancer Treatments  Voice of America - VOA News', 'url': 'https://news.google.com/rss/articles/CBMihgFBVV95cUxPMDA4UFd5blQ5VjFUSy1LYUtxeVVhSF9GeGY1RkJaZUwybjVFbG80bXZaa2dfZEREcVFTbXoybktENVA1NzU5aW9MTmpscFI5X3llOUNnd21Bb2Iwd2NGMC1uMXdvaEJMMTVrZHFiNDFLWEJHRWtYRXR5djFaQ3FjRzlBaGtiQdIBiAFBVV95cUxNbmp3bEFiM0JydUhTYUU0bkNrd3p1c0pBZ2x6SXRQeFdmYXo2UTVaRlhJVzlVQnUybGxyR1RnbEplNlpGZzBzN3Eza21vOFBISEpaYzUxS0xWa3hvZC15cWVrN1UtQWZrbUZyd0FCZURnY2g5azN5TnZqVEd5N1hBUEFoLXBJVlpQ?oc=5&hl=en-US&gl=US&ceid=US:en'}
